Xlspas-A Tablet is a combination pharmaceutical formulation containing Drotaverine 80 mg and Aceclofenac 100 mg, designed for the effective management of pain associated with smooth muscle spasms and inflammatory conditions. Drotaverine, an antispasmodic agent, acts by inhibiting phosphodiesterase-IV, leading to increased intracellular cyclic AMP levels and subsequent relaxation of smooth muscle tissue, thereby alleviating spasmodic pain. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts its therapeutic effects by selectively inhibiting cyclooxygenase enzymes (COX-1 and COX-2), resulting in decreased synthesis of prostaglandins responsible for inflammation, pain, and fever. The synergistic action of these two active ingredients provides rapid relief from musculoskeletal pain, including conditions such as dysmenorrhea, renal colic, biliary colic, and various inflammatory disorders like arthritis. Xlspas-A is indicated for short-term use to manage acute episodes of pain and inflammation. It should be used with caution in patients with a history of gastrointestinal ulcers, renal or hepatic impairment, and cardiovascular diseases. Common adverse effects may include gastrointestinal discomfort, nausea, dizziness, and hypersensitivity reactions. Consultation with a healthcare professional is advised before initiating therapy to ensure appropriate use and to monitor for potential drug interactions and contraindications.